Skip to main content
padlock icon - secure page this page is secure

A Plasmon-Enhanced Fluorescence Protein Microchip with High-Sensitivity for Multiple Islet Autoantibodies Measurements in Autoimmune Diabetes Diagnosis

Buy Article:

$106.34 + tax (Refund Policy)

Correct classification diagnosis of diabetes is critical for timely and appropriate treatment, which partially depends on the multiple islet autoantibodies measurement and combined analysis. This study reports plasmon-enhanced fluorescence protein microchip method, a fast, high-throughput, and high sensitive method, to measure circulating islet autoantibodies. This method can achieve islet autoantibodies combined analysis within a few hours by using a few microliters of serum. Combined islet autoantibodies analysis improved discriminatory ability, especially the diagnostic sensitivity. Furthermore, by applying this method, we found 4 out of 6 diabetes atypical patients who were clinically highly suspected of having autoimmune diabetes but had a negative result of glutamic acid decarboxylase antibody and insulinoma-associated protein 2 antibody by enzyme-linked immunosorbent assay were positive at least 1 out of 4 islet autoantibodies, largely reducing the rate of missed diagnosis of autoimmune diabetes and further validating its clinical value. This study shows the great clinical potentials of plasmon-enhanced fluorescence protein microchips.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: AU NANOSTRUCTURE; AUTOIMMUNE DIABETES; COMBINED ANALYSIS; ISLET AUTOANTIBODIES; METAL ENHANCED FLUORESCENCE; MICROCHIP

Document Type: Research Article

Publication date: August 1, 2018

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more